Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Rohit Lakhanpal is an Ophthalmologist in Baltimore, Maryland. Dr. Lakhanpal is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy. Dr. Lakhanpal is currently accepting new patients.

Michael Elman is an Ophthalmologist in Baltimore, Maryland. Dr. Elman is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy. Dr. Elman is currently accepting new patients.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Amir H. Kashani, M.D., Ph.D. is a retina specialist, surgeon, the Boone Pickens Professor in Ophthalmology and a professor in bioengineering treating patients at Wilmer Eye Institute’s East Baltimore and Columbia locations. Dr. Kashani specializes in the diagnosis and treatment of medical and surgical retinal diseases including diabetic retinopathy, retinal vein occlusions, age-related macular degeneration, epiretinal membranes and retinal detachments as well as other common retinal diseases. Dr. Kashani is an NIH-funded clinician-scientist studying the pathophysiology of retinal vascular diseases, such as diabetic retinopathy, vascular cognitive impairment and dementia in human patients using cutting-edge, noninvasive imaging methods such as optical coherence tomography angiography. He has co-authored more than 50 peer-reviewed articles in the scientific literature, several subject reviews, and an ophthalmology handbook titled Optical Coherence Tomography and OCT Angiography: Clinical Reference and Case Studies. Dr. Kashani is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.

Edward Goldman is an Ophthalmologist in Owings Mills, Maryland. Dr. Goldman is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Retinal Artery Occlusion, and Diabetic Macular Edema (DME). Dr. Goldman is currently accepting new patients.

Matthew Speicher is an Ophthalmologist in Baltimore, Maryland. Dr. Speicher is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Hyphema, Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Speicher is currently accepting new patients.

Eric Suan is an Ophthalmologist in Baltimore, Maryland. Dr. Suan is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Artery Occlusion.

Timothy D. Polk, MD, specializes in comprehensive ophthalmology. He is affiliated with UPMC Memorial. Dr. Polk completed his fellowships at the University of Iowa Hospitals and Clinics and Bascom Palmer Eye Institute, residency at Greater Baltimore Medical Center and medical degree at the University of Virginia School of Medicine. Dr. Polk is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, Retinal Vein Occlusion, and Vitrectomy.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Raymond Sjaarda is an Ophthalmologist in Baltimore, Maryland. Dr. Sjaarda is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Detachment, and Vitrectomy. Dr. Sjaarda is currently accepting new patients.

John Thompson is an Ophthalmologist in Baltimore, Maryland. Dr. Thompson is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Geographic Atrophy. Dr. Thompson is currently accepting new patients.

Michael Grodin is an Ophthalmologist in Lutherville, Maryland. Dr. Grodin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion. Dr. Grodin is currently accepting new patients.

Joseph Harlan is an Ophthalmologist in Lutherville, Maryland. Dr. Harlan is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Artery Occlusion, and Age-Related Macular Degeneration (ARMD). Dr. Harlan is currently accepting new patients.

Lisa Schocket is an Ophthalmologist in Baltimore, Maryland. Dr. Schocket is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Schocket is currently accepting new patients.

Vinod Lakhanpal is an Ophthalmologist in Owings Mills, Maryland. Dr. Lakhanpal is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.